Thus, this study further explored the impact of SX on gut microbiota and the expression of key protein in lipid metabolism PPARα and apoB48 in NAFLD via the gut-liver axis (Figure 1). The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.